Cargando…
Tocilizumab in COVID-19 management: addressing time of starting treatment
Autores principales: | Khiali, Sajad, Entezari-Maleki, Taher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986926/ https://www.ncbi.nlm.nih.gov/pubmed/34992089 http://dx.doi.org/10.1136/ejhpharm-2021-003149 |
Ejemplares similares
-
Enhanced donor screening for faecal microbial transplantation during COVID-19
por: Parvathy, Seema Nair, et al.
Publicado: (2021) -
Facing postdural puncture headache in COVID-19 times
por: Rocha-Romero, Andrés, et al.
Publicado: (2021) -
Is sitagliptin effective for the treatment of COVID-19?
por: Memiş, Hasan, et al.
Publicado: (2022) -
Breast feeding at the time of COVID-19: do not forget expressed mother’s milk, please
por: Davanzo, Riccardo
Publicado: (2020) -
Working from home in the time of covid-19: how to best preserve occupational health?
por: Bouziri, Hanifa, et al.
Publicado: (2020)